Chargement en cours...
Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52
Castration‐resistant prostate cancer (CRPC) is the emergence of prostate cancer cells that have adapted to the androgen‐depleted environment of the prostate. In recent years, targeting multiple chaperones and co‐chaperones (e.g., Hsp27, FKBP52) that promote androgen receptor (AR) signaling and/or no...
Enregistré dans:
| Publié dans: | Mol Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378613/ https://ncbi.nlm.nih.gov/pubmed/28252832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12028 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|